AuntMinnie

MARCH 26, 2024

Food and Drug Administration's (FDA) approvals of radiopharmaceuticals for neuroendocrine tumors and then for prostate cancer, theranostics has picked up momentum in clinical practice, propelled by encouraging research. Since 2013 we've had several more radiopharmaceutical therapies get FDA approval.

Nuclear Medicine 122

Nuclear Medicine Radiopharmaceuticals Radiation Health Science 122

AuntMinnie

JUNE 11, 2024

TORONTO – The radiopharmaceutical Pluvicto improves progression-free survival in patients with metastatic prostate cancer who haven’t undergone taxane therapy, according to research presented at the SNMMI meeting. Oliver Sartor, MD The study, which was awarded SNMMI’s Abstract of the Year award, shared data from the phase III PSMAfore trial.

Nuclear Medicine 122

Nuclear Medicine Radiopharmaceuticals Radiograph Radiographer 122

Imaging Technology

JUNE 15, 2023

The clinical trial will use this investigational radiopharmaceutical to help understand if patients have CD8+ T cells in their tumors and will, therefore, be more likely to respond to immune checkpoint inhibitors, the main class of immunotherapies currently approved for use.

Radiopharmaceuticals 87

Radiopharmaceuticals Pharmaceutical Nuclear Medicine PET Scan 87

Imaging Technology

JANUARY 5, 2024

milla1cf Fri, 01/05/2024 - 11:32 January 5, 2024 — NorthStar Medical Radioisotopes, LLC , a global innovator in development, production and commercialization of radiopharmaceuticals used to detect and treat cancer and other serious diseases, and Curadh MTR Inc. Chief Executive Officer of NorthStar Medical Radioisotopes.

Radiopharmaceuticals 52

Radiopharmaceuticals Medical Nuclear Medicine Pharmaceutical 52

AuntMinnie

FEBRUARY 20, 2024

Blue Earth Therapeutics is highlighting early clinical results from a German trial investigating the use of a lutetium-177 (Lu-177)-labeled prostate specific antigen (PSMA) radiopharmaceutical. and its findings were published in December in the Journal of Nuclear Medicine. Blue Earth said.

Clinic 40

Clinic Nuclear Medicine Radiopharmaceuticals Hospital 40

TTG Imaging Solutions

AUGUST 1, 2023

Martin Shirley was appointed the role of TTG Imaging Solutions Executive Vice President Sales, Marketing & Clinical Operations in April of 2023 as part of TTG Imaging Solutions acquisition of Digirad Health, Inc and its subsidiaries Digirad Diagnostic Imaging, Inc and Digirad Imaging Solution, Inc. The post Martin B.

Nuclear Medicine 40

Nuclear Medicine Clinic Radiopharmaceuticals Diagnostic Imaging 40

TTG Imaging Solutions

AUGUST 1, 2023

Martin Shirley was appointed the role of TTG Imaging Solutions Executive Vice President Sales, Marketing & Clinical Operations in April of 2023 as part of TTG Imaging Solutions acquisition of Digirad Health, Inc and its subsidiaries Digirad Diagnostic Imaging, Inc and Digirad Imaging Solution, Inc. The post Martin B.

Nuclear Medicine 40

Nuclear Medicine Clinic Radiopharmaceuticals Diagnostic Imaging 40

AuntMinnie

APRIL 4, 2024

A decade ago, only a few radiopharmaceutical agents were used to help treat cancer patients. They're also mindful of the multiple dedicated teams required to build a theranostics clinic properly. He also helped lead the theranostics conference at the Society of Nuclear Medicine and Molecular Imaging (SNMMI) 2024 midwinter meeting.

Nuclear Medicine 86

Nuclear Medicine Radiation Oncology Nursing Radiation 86

Imaging Technology

JUNE 10, 2024

Urbain, MD, PhD, FASNC, professor of Radiology/Nuclear Medicine and Medicine, has been named president-elect of the Society of Nuclear Medicine and Molecular Imaging (SNMMI). SNMMI introduced a new slate of officers during its 2024 Annual Meeting, held June 8-11 in Toronto. “As

Nuclear Medicine 59

Nuclear Medicine Radiopharmaceuticals Hospital Health Science 59

AuntMinnie

JUNE 20, 2024

Food and Drug Administration's (FDA) approvals of radiopharmaceuticals for neuroendocrine tumors and then for prostate cancer, theranostics has picked up momentum in clinical practice, propelled by encouraging research. Since 2013 we've had several more radiopharmaceutical therapies get FDA approval.

Nuclear Medicine 52

Nuclear Medicine Radiopharmaceuticals Radiation Health Science 52

AuntMinnie

JUNE 9, 2024

Jean-Luc Urbain, MD, PhD, has been named president-elect of the Society of Nuclear Medicine and Molecular Imaging (SNMMI). Urbain, a professor of radiology and nuclear medicine, has served in multiple roles within SNMMI, in addition to his most recent post as vice president-elect. Jean-Luc Urbain, MD, PhD. “As

Nuclear Medicine 40

Nuclear Medicine Radiopharmaceuticals Government Education 40

AuntMinnie

JUNE 10, 2024

Evans, PhD, has been named the 2024 recipient of the Society of Nuclear Medicine and Molecular Imaging (SNMMI) Sam Gambhir Trailblazer Award. He will be honored at the SNMMI's annual meeting in Toronto. Evans earned his PhD in organic chemistry from the Scripps Research Institute.

Nuclear Medicine 40

Nuclear Medicine Radiopharmaceuticals Pharmaceutical Clinic 40

Imaging Technology

DECEMBER 12, 2023

milla1cf Tue, 12/12/2023 - 10:00 December 12, 2023 — IBA , a world leader in particle accelerator technology and of radiopharmaceutical production solutions is pleased to announce the start of the installation of a Cyclone 30XP in Poland. Beyond At-211, IBA is also pioneering novel accelerator applications for other theranostic isotopes.

Radiopharmaceuticals 111

Radiopharmaceuticals Nuclear Medicine Clinic IT 111

AuntMinnie

JUNE 14, 2024

Nuclear medicine injection extravasations and medical events will be the focus of the Advisory Committee on the Medical Uses of Isotopes (ACMUI)'s public teleconference on June 17. Nuclear Regulatory Commission (NRC) rulemaking. That might do away with diagnostic concerns, Flannery noted.

Nuclear Medicine 52

Nuclear Medicine Radiation Radiopharmaceuticals Medical 52

Imaging Technology

JUNE 26, 2023

Mahmood was presented the award by the Society of Nuclear Medicine and Molecular Imaging (SNMMI) at its 2023 Annual Meeting. Award recipients will have initiated, developed, and successfully implemented unique and significant transformative value within the field of nuclear medicine and molecular imaging.

Nuclear Medicine 82

Nuclear Medicine Education Radiopharmaceuticals Hospital 82

AuntMinnie

MARCH 25, 2024

PET/CT is poised to become a key tool for imaging the coronary arteries – a clinical imaging exam that can reveal early warning signs of fatal conditions when patients present with symptoms of chest pain, experts say. The game-changer could be the pending U.S. approval of new PET radiotracers, such as F-18 flurpiridaz , he said.

Nuclear Medicine 128

Nuclear Medicine Radiopharmaceuticals Disease Radiation 128

TTG Imaging Solutions

MAY 26, 2022

We have expanded our pharmacy presence both physically and through strategic partnerships while also expanding our footprint of clinical technologists in the regions that business unit serves. All attendees are encouraged to visit and meet with members of the leadership, sales, and service team to discover TTG’s end-to-end solution.

Nuclear Medicine 52

Nuclear Medicine Imaging Radiopharmaceuticals Medical Imaging 52

TTG Imaging Solutions

FEBRUARY 17, 2022

Be sure to visit us at booth #304 Monday, February 21 and Tuesday, February 22 to discover solutions for equipment, nationwide service, parts, and clinical support. We aim to maximize customer satisfaction through a relentless pursuit of quality, a broad portfolio of services, and commitment to continuous improvement.

Nuclear Medicine 52

Nuclear Medicine Imaging Radiopharmaceuticals Diagnostic Imaging 52

AuntMinnie

JUNE 3, 2024

With therapeutic radiopharmaceuticals coming to market quickly and available to smaller institutions around the U.S., My vision of a theranostic center includes a flagship facility that has a PET/CT scanner, a SPECT/CT scanner, and then multiple rooms for infusions of radiopharmaceuticals," Siegel explained.

Nuclear Medicine 105

Nuclear Medicine Radiopharmaceuticals Radiation Radiation Oncology 105

Imaging Technology

JUNE 20, 2024

For the practice of precision care in molecular imaging and nuclear medicine, this begins with the production of radioisotopes for use in diagnostic tracers, which are administered to patients, attach to specific biomarkers, and release radioactive emissions to provide clinicians detailed molecular information unique to each patient.

Healthcare 80

Healthcare Healthcare Nuclear Medicine Computed Tomography 80

TTG Imaging Solutions

MAY 5, 2023

operates a diagnostic imaging turnkey business and serves as an OEM and service provider for a well-respected portfolio of fixed and mobile solid-state nuclear medicine cameras. Digirad Health, Inc. Digirad has provided unique solutions to hospitals and outpatient providers for more than two decades.

Imaging 52

Imaging Radiopharmaceuticals Radiation Oncology Nuclear Medicine 52

Imaging Technology

JUNE 21, 2023

By the end of June 2023, commercial production across the country will be underway at the 31 PETNET radiopharmacies Blue Earth Diagnostics included in its New Drug Application for POSLUMA, marking a record number of sites authorized for the manufacturing of a radiopharmaceutical upon its initial FDA approval.

Diagnostic 75

Diagnostic Radiopharmaceuticals Imaging Medicare 75

TTG Imaging Solutions

NOVEMBER 1, 2021

PITTSBURGH, PA (November 1, 2021) – TTG Imaging Solutions, LLC (TTG) announced today executive leadership changes that will drive the company’s next phase of growth following its 9th acquisition in 2 years of Medical Imaging Technologies, an Akron, Ohio based nuclear medicine equipment and service organization.

Nuclear Medicine 52

Nuclear Medicine Imaging Radiopharmaceuticals Medical Imaging 52

Imaging Technology

JUNE 29, 2023

milla1cf Thu, 06/29/2023 - 21:10 June 29, 2023 — Blue Earth Therapeutics , a Bracco company and emerging leader in the development of innovative next generation therapeutic radiopharmaceuticals, today announced highlights from early clinical and preclinical studies of 177Lu-rhPSMA-10.1 177Lu-rhPSMA-10.1 177Lu-rhPSMA-10.1

Clinic 82

Clinic Nuclear Medicine Radiopharmaceuticals Radiation 82

Open Medscience

MAY 14, 2024

Positron Emission Tomography Imaging has advanced with cutting-edge technologies, enhancing diagnostic accuracy and expanding clinical applications dramatically. The post Breakthroughs in Positron Emission Tomography Imaging appeared first on Open MedScience.

Imaging 52

Imaging Diagnostic Clinic Nuclear Medicine 52

Imaging Technology

APRIL 3, 2023

Mr. Merrick continued, “Demand for therapeutic radiopharmaceuticals is increasing rapidly. NorthStar has further deepened and broadened our business platform with the recent establishment of a full-scale radiopharmaceutical CDMO/CMO services unit. Ac-225 using advanced, environmentally preferable electron accelerator technology.

Medical 82

Medical Radiopharmaceuticals Pharmaceutical Radiation 82

AuntMinnie

JANUARY 19, 2024

Centers for Medicare and Medicaid Services (CMS), for example, did not cover amyloid PET scans outside of clinical trials for Medicare beneficiaries and only covered one scan per patient’s lifetime. This has led to inadequate payment for precision radiopharmaceuticals and challenges for some providers seeking to offer these imaging services.

Disease 52

Disease Medicare Imaging PET Scan 52